[1] CaroJF , SinhaMK , KolaczynskiJW , etal.Leptin:thetaleofanobesi tygene[J].Diabetes, 1996, 45 (11) ∶1455-62.
|
[2] KimuraK , TsudaK , BabaA , etal.Invdvementofnitricoxideinen dothelium-dependentarterialrelaxationbyleptin[J].BiochemBiophysResCommun, 2000, 273 (2) ∶745-9.
|
[3] PotterJJ, WomackL , MezeyE , etal.Transdifferentiationrathepaticstellatecellsresultsinleptinexpression[J].BiochemBiophysResCom mun.1998, 244 (1) ∶178-82.
|
[4]中华医学会.酒精性肝病诊断标准[J].中华肝脏病杂志, 2003, 11 (2) ∶72.
|
[5]王泰龄, 赵静波, 张道明, 等.酒精性肝病[M].北京:中国医药科技出版社, 2001∶25-39.
|
[6] IkejimaK , HondaH , HiroseM , etal.Asaprofibrogenicfactorintheliver[J].Gastroenterology, 2000, 118∶A1014.
|
[7] IkejimaK , HondaH , YoshikawaM , etal.Leptinaugmentsinflammato ryandprofibrogenicresponsesinthemurineliverinducedbyhepatotoxicchemicals[J].Hepatology, 2001, 34 (2) ∶288-97.
|
[1] | XU Zhen, LIU ShouSheng, TAN Jie, SUN BaoKai, DU ShuiXian, XIN YongNing, XUAN ShiYing. Expression and significance of leptin and adiponectin in serum of patients with nonalcoholic fatty liver disease and coronary heart disease[J]. Journal of Clinical Hepatology, 2020, 36(11): 2478-2483. doi: 10.3969/j.issn.1001-5256.2020.11.016 |
[2] | Wang CuiHua, Yue Yan. Research progress in relationship of leptin and adiponectin with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(8): 1351-1354. doi: 10.3969/j.issn.1001-5256.2015.08.045 |
[3] | Kong Yin, Zhang LingYi. The role of leptin and adiponectin in non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2011, 27(4): 441-443. |
[4] | Zhao ZhengBin, Li JunFeng, Huang ShuangSheng, Zhang LiTing, Chen Hong. The advances of profibrogenic research of leptin and its signaling pathways in hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1106-1108. |
[6] | Wang ChunPing, Zhang Ming. Evaluation of leptin receptor Gln223Arg polymorphism in patients with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2008, 24(3): 194-196. |
[7] | Li Mei, Liang YingYin, Lin HongZheng, Xu Ya, Chen SongLin, Liu SiChun. Clinical analysis of 32 cases with alcoholic liver disease and alcohol with drawal syndrome[J]. Journal of Clinical Hepatology, 2007, 23(1): 38-39. |
[8] | Li YuQin, Po YunFeng, Chen ZhaoJie, Ding BaiJing, Tang TongYu, Wang Dan, Gao YanHang, Jin JingLan. Relationship between the levels of serum leptin and insulin resistance in patients with fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(5): 360-361. |
[9] | Li RuiYan, Xiong JinHu. Evaluation of the clinical value of the concentration of leptin in viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 96-97. |
[10] | Zheng JiMin, Jiang HuiQing, Lu: XiaoPing, Zhang XiangMei. Measurement of ghrelin leptin levels in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2006, 22(3): 195-196. |
[12] | Liu FengHai, Sun LinYu, Tan HaiYan, Liu XiaoLi. The clinical significance of serum leptin levels in patients with nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2006, 22(1): 41-42. |
[13] | Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin. Relationship between leptin resistance and nonalcoholic fatty liver in male patients.[J]. Journal of Clinical Hepatology, 2006, 22(1): 39-41. |
[14] | Wang RuiKe, Liu XiuZhen, Zhang GuYun, Li Hong, Sun ZhaoCui, Zhang JinAn. Monitoring the change of interleukin-6 in the alcoholic liver disease and its clinical significance[J]. Journal of Clinical Hepatology, 2005, 21(2): 100-101. |
[15] | Wang HaiQin, Li JuanJuan. Therapeutic effect of GSH on the treatment of alcoholic liver diseases.[J]. Journal of Clinical Hepatology, 2004, 20(6): 355-356. |
[16] | Li ChuanFeng, Huang YongCan, Qiu Xiang, Po YunFeng. Clinical analysis of 146 cases of alcoholic liver diseases.[J]. Journal of Clinical Hepatology, 2004, 20(3): 157-158. |
[17] | Lu ZhenYa, Wang QunYan, Rao WeiQiang, Cai WeiMin, Liu RongHua. The relationship between serum leptin levels and the levels of fibrosis marks in patients with hepatitis B.[J]. Journal of Clinical Hepatology, 2004, 20(2): 85-86. |